Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells

 

Tuberculosis Drug Candidate SQ109 Granted Orphan Drug Status

Filed in archive Drugs, Vaccines and Therapeutics by ruth on October 30, 2007

Tuberculosis_xray.jpg


The U.S. Food and Drug Administration and the European Medicines Agency has granted "orphan drug" status to SQ109, an antimicrobial agent against drug-resistant tuberculosis jointly developed by the National Institute of Allergy and Infectious Diseases (NIAID) and biotech company Sequella, Inc. This orphan designation will help accelerate clinical testing of SQ109, which promises simple and more effective treatment regimen than current methods which require six to nine months of treatment.
SQ109 was discovered by NIAID scientists in 1999 and developed with grant and contract support from NIAID and contributions by the National Cancer Institute/NIAID Inter-Institute Program for the Development of AIDS-related Therapeutics. NIAID licensed the SQ109 technology to Sequella in March 2006 under a Cooperative Research and Development Agreement.


Source: NIAID
Photo: An anteroposterior X-ray of a patient diagnosed with advanced bilateral pulmonary tuberculosis. This AP X-ray of the chest reveals the presence of bilateral pulmonary infiltrate (white triangles), and "caving formation" (black arrows) present in the right apical region.The diagnosis is far-advanced tuberculosis. Source: Wikipedia


Advertisement


Permalink: Tuberculosis Drug Candidate SQ109 Granted Orphan Drug Status
Tags: tuberculosis  drug+resistance  drug+development  drug+discovery  antimicrobials  drug  tuberculosis+drug  d 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/99258



Advertisement


Advertisement


CW ToolbarInstall
RSSrss   | See all blog subscribe options
Googlegoogle   |   What is RSS?
Yahoo!yahoo
AddthisAddThis Feed Button
BloglinesBloglines
Newsletter
Advertisement - Book yours here.

Use our search feature to look for other interesting posts

Just this blog Whole network
 
  • Would you like to have a new interactive marketing channel for your company? Learn more about Sponsored Blogs with Creative Weblogging. See how we helped companies like Weblin and cellity reach their goals.
  • Would you like to reach millions of blog readers every day? See you banner on hundreds of blogs with TierOneAds? Stay in control measuring conversion in real time. Register now.
  • Would you like to make more money blogging? Use TierOneAds a new platform that allows you as a blogger to set your prices per impression. Register now.
  • Do you have a blog with more than 50k page views from the US? Let us market your blog and earn great fix payments and bonuses.
  • Would you like to see your text link here? Let us know!
Advertisement
Book yours here.



  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'
  • Other blogs in the same channel in the Creative Weblogging Network

Advertisement -
Book yours here..






Advertisement - Book yours here..
 
Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells